17 alpha-hydroxyprogesterone caproate has been researched along with Polycystic Ovarian Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abendstein, BJ; Kreuzer, E; Rjosk, HK; Schwärzler, P | 1 |
1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Polycystic Ovarian Syndrome
Article | Year |
---|---|
Preliminary experience with steroidal ovarian suppression for prevention of severe ovarian hyperstimulation syndrome in IVF patients.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Chorionic Gonadotropin; Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Humans; Hydroxyprogesterones; Infertility, Female; Injections, Intramuscular; Ovarian Hyperstimulation Syndrome; Ovary; Polycystic Ovary Syndrome; Pregnancy; Progesterone; Risk Factors | 2001 |